Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2020 Dec 1;35(1):294. doi: 10.1038/s41375-020-01071-7

Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC

I Tirado-Gonzalez 1,#, E Czlonka 1,#, A Nevmerzhitskaya 1,#, D Soetopo 1, E Bergonzani 1, A Mahmoud 1, A Contreras 1, I Jeremias 2,3, U Platzbecker 4,5, J P Bourquin 6, U Kloz 6, F Van der Hoeven 7, H Medyouf 1,8,9,
PMCID: PMC7962559  PMID: 33262529

Correction to: Leukemia

10.1038/leu.2017.346

This article was originally published under NPG’s License to Publish, but has now been made available under a CCBY license. The PDF and HTML versions of the paper have been modified accordingly.

Footnotes

The original article can be found online at 10.1038/leu.2017.346.

These authors contributed equally: I Tirado-Gonzalez, E Czlonka, A Nevmerzhitskaya


Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES